Αποτελέσματα αναζήτησης - Dijkmans, B A C
- Εμφανίζονται 1 - 20 Αποτελέσματα από 24
- Μετάβαση στην Επόμενη Σελίδα
-
1
-
2
Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implic... από van Kuijk, A W R, Reinders‐Blankert, P, Smeets, T J M, Dijkmans, B A C, Tak, P P
Έκδοση 2006Κείμενο -
3
-
4
Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis από van Halm, V P, Slot, M C, Nurmohamed, M T, Tervaert, J W Cohen, Dijkmans, B A C, Voskuyl, A E
Έκδοση 2006Κείμενο -
5
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases από Burmester, G R, Mease, P, Dijkmans, B A C, Gordon, K, Lovell, D, Panaccione, R, Perez, J, Pangan, A L
Έκδοση 2009Κείμενο -
6
2-Deoxy-2-[F-18]fluoro-D-glucose Joint Uptake on Positron Emission Tomography Images: Rheumatoid Arthritis Versus Osteoarthritis από Elzinga, E. H., van der Laken, C. J., Comans, E. F. I., Lammertsma, A. A., Dijkmans, B. A. C., Voskuyl, A. E.
Έκδοση 2007Κείμενο -
7
High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review από van der Weijden, M. A. C., Claushuis, T. A. M., Nazari, T., Lems, W. F., Dijkmans, B. A. C., van der Horst-Bruinsma, I. E.
Έκδοση 2012Κείμενο -
8
-
9
-
10
-
11
Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies από van der Weijden, M. A. C., van Denderen, J. C., Lems, W. F., Heymans, M. W., Dijkmans, B. A. C., van der Horst-Bruinsma, I. E.
Έκδοση 2010Κείμενο -
12
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial από van der Heijde, D, Schiff, M H, Sieper, J, Kivitz, A J, Wong, R L, Kupper, H, Dijkmans, B A C, Mease, P J, Davis, J C
Έκδοση 2008Κείμενο -
13
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheuma... από Vis, M, Havaardsholm, E A, Haugeberg, G, Uhlig, T, Voskuyl, A E, van de Stadt, R J, Dijkmans, B A C, Woolf, A D, Kvien, T K, Lems, W F
Έκδοση 2006Κείμενο -
14
Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti‐infliximab in responders and non‐responders to therapy for rheumatoid arthritis από van der Laken, C J, Voskuyl, A E, Roos, J C, van Walsum, M Stigter, de Groot, E R, Wolbink, G, Dijkmans, B A C, Aarden, L A
Έκδοση 2007Κείμενο -
15
A prospective, randomised, placebo-controlled study to identify biomarkers associated with active treatment in psoriatic arthritis: effects of adalimumab treatment on synovial tiss... από van Kuijk, A W R, Gerlag, D M, Vos, K, Wolbink, G, de Groot, M, de Rie, M A, Zwinderman, A H, Dijkmans, B A C, Tak, P P
Έκδοση 2008Κείμενο -
16
Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage από de Vries‐Bouwstra, J K, Goekoop‐Ruiterman, Y P M, Wesoly, J, Hulsmans, H J, de Craen, A J M, Breedveld, F C, Dijkmans, B A C, Allaart, C F, Huizinga, T W J
Έκδοση 2007Κείμενο -
17
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor α expression in the synovium από Wijbrandts, C A, Dijkgraaf, M G W, Kraan, M C, Vinkenoog, M, Smeets, T J, Dinant, H, Vos, K, Lems, W F, Wolbink, G J, Sijpkens, D, Dijkmans, B A C, Tak, P P
Έκδοση 2008Κείμενο -
18
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients από van der Pouw Kraan, T C T M, Wijbrandts, C A, van Baarsen, L G M, Voskuyl, A E, Rustenburg, F, Baggen, J M, Ibrahim, S M, Fero, M, Dijkmans, B A C, Tak, P P, Verweij, C L
Έκδοση 2007Κείμενο -
19
Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis από Nielen, M M J, van Schaardenburg, D, Reesink, H W, Twisk, J W R, van de Stadt, R J, van der Horst‐Bruinsma, I E, de Koning, M H M T, Habibuw, M R, Dijkmans, B A C
Έκδοση 2006Κείμενο -
20
Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis από Peters, M J L, Vis, M, van Halm, V P, Wolbink, G J, Voskuyl, A E, Lems, W F, Dijkmans, B A C, Twisk, J W R, de Koning, M H M T, van de Stadt, R J, Nurmohamed, M T
Έκδοση 2007Κείμενο